Compounds > chlorambucil

chlorambucil and fluorodeoxyglucose f18

chlorambucil has been researched along with fluorodeoxyglucose f18 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borel, M; Coudert, P; Debiton, E; Galmier, MJ; Madelmont, JC; Madesclaire, M; Reux, B; Weber, V1
Chezal, JM; Coudert, P; Debiton, E; Madelmont, JC; Miot-Noirault, E; Reux, B; Weber, V1
Chezal, JM; Coudert, P; Debiton, E; El Hilali, M; Galmier, MJ; Leal, F; Miot-Noirault, E; Reux, B; Vivier, M; Weber, V1

Other Studies

3 other study(ies) available for chlorambucil and fluorodeoxyglucose f18

ArticleYear
Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives.
    Bioorganic & medicinal chemistry, 2008, May-01, Volume: 16, Issue:9

    Topics: Cell Line; Cell Proliferation; Chlorambucil; Drug Screening Assays, Antitumor; Fibroblasts; Fluorodeoxyglucose F18; Humans; Molecular Structure; Stereoisomerism

2008
Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
    Investigational new drugs, 2011, Volume: 29, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chlorambucil; Fluorodeoxyglucose F18; Humans; Maximum Tolerated Dose; Mice; Xenograft Model Antitumor Assays

2011
Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.
    Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20

    Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorambucil; Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Inhibitory Concentration 50; Molecular Structure; Structure-Activity Relationship

2017